John R. Downs
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolism, Diabetes, and Cancer, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels(1998)5,284 cited
- → Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials(2010)2,426 cited
- → Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events(2001)1,558 cited
- → Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins(2012)789 cited
- → Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials(2019)772 cited
- → HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials(2014)704 cited
- → Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events(2014)579 cited
- → Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)(2000)566 cited
- → Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials(2022)230 cited
- → Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients(2013)193 cited